On the role of PGD2 metabolites as markers of mast cell activation in asthma

Acta Physiologica Scandinavica, Supplement

Volumn 166, Issue 644, 1999, Pages 1-74

  O'Sullivan, Siobhán ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CELL PROTEIN; HISTAMINE; LEUKOTRIENE E4; LYSINE ACETYLSALICYLATE; METHACHOLINE; N METHYLHISTAMINE; PROSTAGLANDIN D2; PROSTAGLANDIN F2; PROSTAGLANDIN E2;

AIRWAY OBSTRUCTION; ALLERGIC ASTHMA; ARTICLE; BICYCLE ERGOMETER; BRONCHOSPASM; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME IMMUNOASSAY; EOSINOPHIL; EXERCISE; FEASIBILITY STUDY; GAS CHROMATOGRAPHY; HOUSE DUST; HUMAN; HUMAN CELL; LAVAGE; MASS SPECTROMETRY; MAST CELL DEGRANULATION; OXIDATION; URINALYSIS; URINARY EXCRETION; ANIMAL; ASTHMA; BIOSYNTHESIS; IMMUNOLOGY; INFLAMMATION; MAST CELL; METABOLISM; PATHOLOGY; REVIEW;

ANIMALS; ASTHMA; DINOPROSTONE; HISTAMINE; HUMANS; INFLAMMATION; MAST CELLS;

EID: 0033109763     PISSN: 03022994     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (375)

1. Adcock JJ, Garland LG 1980. A possible rolefor lipoxygenase products as regulators of airway smooth muscle reactivity. Br J Pharmacol 69;167-169
2. 4 and to methacholine in patients with asthma and normal controls. N Engl J Med 315;480-484.
3. 2 antagonist, reduces bronchial hyperresponsiveness in asthmatics. Chest 109;338-342
4. 2 by human platelets. Thromb Res 11;485-496
5. 2 in the long-lasting airways vasodilatation induced by allergen in the sensitized pig. Acta Physiol Scand 143;93-103
6. Anderson A, Daviskas E, CM S. 1989. Exercise-induced asthma: a difference in opinion regarding the stimulus. Allergy Proc 10;215-216
7. Anderson S. Exercise-induced athma. The state of the art. Chest 87;191S-195S (1985)
8. 2 synthesis in human thrombocytes. Experientia 34;1494-1496
9. 4 on the airway responsiveness to histamine in subjects with asthma and normal subjects. J Allergy Clin Immunol 82;654-660
10. 3) of histamine receptor. Nature 302;832-837
11. Ash AS, Schild HO. 1966. Receptors mediating some actions of histamine. Br J Pharmacol 27;427-439
12. Austen KF, Orange RP. 1975. Bronchial asthma: the possible role of the chemical mediators of immediate hypersensitivity in the pathogenesis of subacute chronic disease. Am Rev Respir Dis 112;423-436
13. 2 in the circulation: demonstration of elevated levels in patients with disorders of systemic mast cell activation. J Allergy Clin Immunol 93;817-824
14. Barnes PJ, Brown MJ. 1981. Venous plasma histamine in exercise- and hyperventilation-induced asthma in man. Clin Sci 61;159-162
15. Beasley R, Roche WR, Roberts JA, Holgate ST. 1989. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 139;806-817
16. 2- and allergen-induced bronchoconstriction. J Appl Physiol 66;1685-1693
17. Bedard M, McClure CD, Schiller NL, Francoeur C, Cantin A, Denis M. 1993. Release of interleukin-8, interleukin-6, and colony-stimulating factors by upper airway epithelial cells: implications for cystic fibrosis. Am J Respir Cell Mol Biol 9;455-462
18. Befus AD, Dyck N, Goodacre R, Bienenstock J. 1987 Mast cells from the human intestinal lamina propria. Isolation, histochemical subtypes, and functional characterization. J Immunol 138;2604-2610
19. Bel EH, Timmers MC, Hermans J, Dijkman JH, Sterk PJ. 1990. The long-term effects of nedocromil sodium and beclomethasone dipropionate on bronchial responsiveness to methacholine in nonatopic asthmatic subjects. Am Rev Respir Dis 141;21-28
20. 4 in normal subjects. Comparison and interaction with methacholine. Am Rev Respir Dis 136;979-984
21. Bianco S, Robuschi M, Petrigni G, Scuri M, Pieroni MG, Refini RM, Vaghi A, Sestini PS. 1993. Efficacy and tolerability of nimesulide in asthmatic patients intolerant to aspirin. Drugs 46 Suppl 1;115-120
22. Bienenstock J, MacQueen G, Sestini P, Marshall JS, Stead RH, Perdue MH. 1991 Mast cell/nerve interactions in vitro and in vivo. Am Rev Respir Dis 143;S55-58
23. Bills TK, Smith JB, Silver MJ. 1977. Selective release of archidonic acid from the phospholipids of human platelets in response to thrombin. J Clin Invest 60;1-6
24. Bjorck T, Gustafsson LE, Dahlen SE. 1992. Isolated bronchi from asthmatics are hyperresponsive to adenosine, which apparently acts indirectly by liberation of leukotrienes and histamine. Am Rev Respir Dis 145;1087-1091
25. 4 and the role of polymorphonuclearleukocytes. Inflammation 6;189-200
26. 2 -receptors. Nature 236;385-390
27. Bland JM, Altman DG. 1986. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1;307-310
28. Booij-Noord H, Vries Kd, Sluiter HJ, Orie NG. 1972. Late bronchial obstructive reaction to experimental inhalation of house dust extract. Clin Allergy 2;43-61
29. Borgeat P, Samuelsson B. 1979. Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187. Proc Natl Acad Sci USA 76;2148-2152
30. Borgeat P, Samuelsson B. 1979. Arachidonic acid metabolism in polymorphonuclear leukocytes: unstable intermediate in formation of dihydroxy acids. Proc Natl Acad Sci USA 76;3213-3217
31. Bradding P, Feather IH, Howarth PH, Mueller R, Roberts JA, Britten K, Bews JP, Hunt TC, Okayama Y, Heusser CH 1992. Interleukin 4 is localized to and released by human mast cells. J Exp Med 176;1381-1386
32. 4: a mediator of vascular permeability. Br J Pharmacol 72;483-486
33. Brocklehurst W. 1960. The release of histamine and formation of a slow-reactibg substance (SRS-A) during anaphylacic shock. J Physiol 151;416-435
34. Broide DH, Eisman S, Ramsdell JW, Ferguson P, Schwartz LB, Wasserman SI. 1990. Airway levels of mast cell-derived mediators in exercise-induced asthma. Am Rev Respir Dis 141;563-568
35. Brown GP, Monick MM, Hunninghake GW. 1988. Human alveolar macrophage arachidonic acid metabolism. Am J Physiol 254;C809-815
36. Brown MJ, Ind PW, Barnes PJ, Jenner DA, Dollery CT. 1980. A sensitive and specific radiometric method for the measurement of plasma histamine in normal individuals. Anal Biochem 109;142-146
37. Bruce C, Taylor WH, Westwood A. 1979. An improved radioenzymatic assay for histamine in human plasma, whole blood, urine, and gastric juice. Ann Clin Biochem 16;259-264
38. Butterfield JH, Kao PC, Klee GC, Yocum MW. 1995. Aspirin idiosyncrasy in systemic mast cell disease: a new look at mediator release during aspirin desensitization. Mayo Clin Proc 70;481-487
39. Calhoun WJ, Lavins BJ, Minkwitz MC, Evans R, Gleich GJ, Cohn J. 1997. Effect of Zafirlukast (Accolate) on Cellular Mediators of Inflammation. Bronchoalveolar lavage fluid findings after segmental antigen challenge. Am J Respir Crit Care Med 157;1381-1389
40. Capron M, Jouault T, Prin L, Joseph M, Ameisen JC, Butterworth AE, Papin JP, Kusnierz JP, Capron A. 1986. Functional study of a monoclonal antibody to IgE Fc receptor (Fc epsilon R2) of eosinophils, platelets, and macrophages. J Exp Med 164;72-89
41. Casale TB, Shelhamer JH, Parrillo JE, Kaliner MA. 1984. Dopamine inhibition of histamine-mediated cutaneous responses. J Allergy Clin Immunol 73;837-841
42. Casale TB, Wood D, Richerson HB, Trapp S, Metzger WJ, Zavala D, Hunninghake GW. 1987. Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with methacholine bronchial hyper-responsiveness. J Clin Invest 79;1197-1203
43. Caughey GH, Zerweck EH, Vanderslice P. 1991. Structure, chromosomal assignment, and deduced amino acid sequence of a human gene for mast cell chymase. J Biol Chem 266;12956-12963
44. Chevrier D, Guesdon JL, Mazie JC, Avrameas S. 1986. Enzyme immunoassay for the measurement of histamine. J Immunol Methods 94;119-125
45. Chhabra SK, Gaur SN. 1989. Effect of long-term treatment with sodium cromoglycate on nonspecific bronchial hyperresponsiveness in asthma. Chest 95;1235-1238
46. Christ-Hazelhof E, Nugteren DH, Van Dorp DA. 1976. Conversions of prostaglandin endoperoxides by glutathione-S-transferases and serum albumins. Biochim Biophys Acta 450;450-461
47. 4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis 143;1025-1029
48. Chung KF. 1986. Role of inflammation in the hyperreactivity of the airways in asthma. Thorax 41;651-662
49. Chung KF, Dent G, McCusker M, Guinot P, Page CP, Barnes PJ. 1987. Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man. Lancet 1;248-251
50. Chung KF, Evans TW, Graf PD, Nadel JA. 1985. Modulation of cholinergic neuro-transmission in canine airways by thromboxane mimetic U46619. Eur J Pharmacol 117;373-375
51. Chung KF, Rogers DF, Barnes PJ, Evans TW. 1990. The role of increased airway microvascular permeability and plasma exudation in asthma. Eur Respir J 3;329-337
52. Church MK, Featherstone RL, Cushley MJ, Mann JS, Holgate ST. 1986. Relationships between adenosine, cyclic nucleotides, and xanthines in asthma. J Allergy Clin Immunol 78;670-675
53. Church MK, Hiroi J. 1987 Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol. Br J Pharmacol 90;421-429
54. Church MK, Lowman MA, Robinson C, Holgate ST, Benyon RC. 1989 Interaction of neuropeptides with human mast cells. Int Arch Allergy Imm 88;70-78
55. 2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP. Cell 65;1043-1051
56. Cockcroft DW, Killian DN, Mellon JJ, Hargreave FE. 1977. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 7;235-243
57. Cockcroft DW, Murdock KY 1987. Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine. J Allergy Clin Immunol 79;734-740
58. Coleman R, Eglen R, Jones R, Narumiya S, Shimizu T, Smith W, Dahlén S-E, Drazen J, Gardiner P, Jackson W, Jones T, Krell R, Nicosia S. 1995. Prostanoid and Leukotriene Receptors: a progress report from the IUPHAR working parties on classification and nomenclature. Adv. Prostaglandin, Thromboxane and Leukotriene Res 23;283-285
59. Coleman RA, Smith WL, Narumiya S. 1994. International Union of Pharmacology classification of prostanoid receptors; properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 46;205-229
60. Copas JL, Borgeat P, Gardiner PJ. 1982. The actions of 5-, 12-, and 15-HETE on tracheobronchial smooth muscle. Prostaglandins Leukotrienes & Medicine 8;105-114
61. 4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest 101;834-846
62. Crimi E, Balbo A, Milanese M, Miadonna A, Rossi GA, Brusasco V. 1992 Airway inflammation and occurrence of delayed bronchoconstriction in exercise-induced asthma. Am Rev Respir Dis 146;507-512
63. Cuss FM, Dixon CM, Barnes PJ. 1986 Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man. Lancet 2;189-192
64. Dahlén B, Kumlin M, Margolskee DJ, Larsson C, Blomqvist H, Williams VC, Zetterstrom O, Dahlén SE. 1993. The leukotriene-receptor antagonist MK-0679 blocks airway obstruction induced by inhaled lysine-aspirin in aspirin-sensitive asthmatics. Eur Respir J 6;1018-1026
65. Dahlén B, Nizankowska E, Szczeklik A, Zetterstrom O, Bochenek G, Kumlin M, Mastalerz L, Pinis G, Swanson LJ, Boodhoo TI, Wright S, Dube LM, Dahlen SE. 1998. Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. Am J Respir Crit Care Med 157;1187-1194
66. Dahlén B, Zetterstrom O. 1990. Comparison of bronchial and per oral provocation with aspirin in aspirin-sensitive asthmatics. Eur Respir J 3;527-534
67. Dahlén B, Zetterström Ö, Dahlén S-E. 1995. Specific problems : asthma induced by aspirin and other non-steroidal anti-inflammatory drugs. In: Manual of asthma management (O'Byrne, P, Thomson, N, eds) Saunders, London, pp. 590-606
68. 4 in the guinea pig depends upon the route of administration. Acta Physiol Scand 118;415-421
69. Dahlén SE, Bjork J, Hedqvist P, Arfors KE, Hammarstrom S, Lindgren JA, Samuelsson B. 1981. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Proc Natl Acad Sci U S A 78;3887-3891
70. Dahlén SE, Hedqvist P, Hammarstrom S, Samuelsson B 1980.. Leukotrienes are potent constrictors of human bronchi. Nature 288;484-486
71. 4 in normal and asthmatic subjects. Am Rev Respir Dis 135;333-337
72. Davies S. 1986. The effect of disodium cromoglycate on exercise-induced asthma. Br Med J 3;1328-1329
73. De Monchy JG, Kauffman HF, Venge P, Koeter GH, Jansen HM, Sluiter HJ, De Vries K 1985. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis 131;373-376
74. Deal EC, Jr., McFadden ER, Jr., Ingram RH, Jr., Strauss RH, Jaeger JJ. 1979. Role of respiratory heat exchange in production of exercise-induced asthma. J Appl Physiol 46;467-475
75. 4 and methacholine on sputum cell differentials in asthma. Am J Respir Crit Care Med 155;1247-1253
76. Diamant Z, Timmers MC, Van der Veen H, Friedman BS, De Smet M, Depre M, Hilliard D, Bel EH, Sterk PJ. 1995. The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo. J Allergy Clin Immunol 95;42-51
77. Djukanovic R, Roche WR, Wilson JW, Beasley CR, Twentyman OP, Howarth RH, Holgate ST. 1990. Mucosal inflammation in asthma. Am Rev Respir Dis 142;434-457
78. Drazen J. 1997. Effects of Cysteinyl Leukotrienes on Human Airways. In: SRS-A to Leukotrienes. The dawning of a new treatment (Holgate, S, Dahlén, S-E, eds) Blackwell Science, London, pp. 189-202
79. Dunlop LS, Smith AP, Piper PJ. 1977 The effect of histamine antagonists on antigen-induced contractions of sensitized human bronchus in vitro. Br J Pharmacol 59;475P
80. Durham SR, Lee TH, Cromwell O, Shaw RJ, Merrett TG, Merrett J, Cooper P, Kay AB 1984. Immunologic studies in allergen-induced late-phase asthmatic reactions. J Allergy Clin Immunol 74;49-60
81. Durham SR, Loegering DA, Dunnette S, Gleich GJ, Kay AB. 1989. Blood eosinophils and eosinophil-derived proteins in allergic asthma. J Allergy Clin Immunol 84;931-936
82. Dworski R, Fitzgerald GA, Oates JA, Sheller JR. 1994. Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med 149;953-959
83. Eggleston PA, Kagey-Sobotka A, Schleimer RP, Lichtenstein LM. 1984. Interaction between hyperosmolar and IgE-mediated histamine release from basophils and mast cells. Am Rev Respir Dis 130;86-91
84. Ehrlich P. 1877. Beiträge zur kenntnis der Anilinfärbungen und ihre Verwendung in der mikroskopischen technik. Arch. Mikros. Anat 13;263-267
85. 2 in the monkey. J Biol Chem 254;4152-4163
86. Enander I, Matsson P, Nystrand J, Andersson AS, Eklund E, Bradford TR, Schwartz LB. 1991. A new radioimmunoassay for human mast cell tryptase using monoclonal antibodies. J Immunol Methods 138;39-46
87. Enerback L. 1966. Mast cells in rat gastrointestinal mucosa. 2. Dye-binding and metachromatic properties. Acta Pathologica et Microbiologica Scandinavica 66;303-312
88. Evans TW, Chung KF, Rogers DF, Barnes PJ. 1987. Effect of platelet-activating factor on airway vascular permeability: possible mechanisms. J Appl Physiol 63;479-484
89. 4. Proc Natl Acad Sci U S A 79;7866-7870
90. Finnerty JP, Holgate ST. 1990. Evidence for the roles of histamine and prostaglandins as mediators in exercise-induced asthma: the inhibitory effect of terfenadine and flurbiprofen alone and in combination. Eur Respir J 3;540-547
91. 4 receptor antagonist. Am Rev Respir Dis 145;746-749
92. Fischer AR, Rosenberg MA, Lilly CM, Callery JC, Rubin P, Cohn J, White MV, Igarashi Y, Kaliner MA, Drazen JM. 1994. Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma. J Allergy Clin Immunol 94;1046-1056
93. Flint KC, Leung KB, Hudspith BN, Brostoff J, Pearce FL, Johnson NM. 1985. Bronchoalveolar mast cells in extrinsic asthma: a mechanism for the initiation of antigen specific bronchoconstriction. Br Med J 291;923-926
94. Flint KC, Leung KB, Pearce FL, Hudspith BN, Brostoff J, Johnson NM. 1985. Human mast cells recovered by bronchoalveolar lavage: their morphology, histamine release and the effects of sodium cromoglycate. Clin Science 68;427-432
95. 2 plays a role in arachidonic acid release and eicosanoid biosynthesis by mast cells. J Immunol 152;5438-5446
96. 2 levels in murine mast cells by recombinant stem cell factor. J Clin Invest 96;1432-1439
97. Foreman JC, Mongar JL, Gomperts BD. 1973. Calcium ionophores and movement of calcium ions following the physiological stimulus to a secretory process. Nature 245;249-251
98. Freed AN. 1995. Models and mechanisms of exercise-induced asthma. Eur Respir J 8;1770-1785
99. Freed AN, Peters SP, Menkes HA. 1987. Airflow-induced bronchoconstriction: role of epithelium and eicosanoid mediators. J Appl Physiol 62;514-581
100. Freedman BJ. 1972. The functional geometry of the bronchi. The relationship between changes in external diameter and calibre, and a consideration of the passive role played by the mucosa in bronchoconstriction. Bull Physiopathol Respir (Nancy) 8;545-552
101. Friedman MM, Kaliner MA. 1987. Human mast cells and asthma. Am RevRespir Dis 135;1157-1164
102. Frigas E, Gleich GJ. 1986. The eosinophil and the pathophysiology of asthma. J Allergy Clin Immunol 77;527-537
103. Frolich JC, Wilson TW, Sweetman BJ, Smigel M, Nies AS, Carr K, Watson JT, Oates JA. 1975 Urinary prostaglandins. Identification and origin. J Clin Invest 55;763-770
104. Fujimura M, Sakamoto S, Kamio Y, Matsuda T. 1993. Effect of a leukotriene antagonist, ONO-1078, on bronchial hyperresponsiveness in patients with asthma. Respir Med 87;133-138
105. 4 in bronchial hyperresponsiveness induced by interleukin-8. Eur Respir J 11;306-311
106. 2 potentiates airway responsiveness to histamine and methacholine. Am Rev Respir Dis 133;252-254
107. Fuller RW, Morris PK, Richmond R, Sykes D, Varndell IM, Kemeny DM, Cole PJ, Dollery CT, MacDermot J 1986. Immunoglobulin E-dependent stimulation of human alveolar macrophages: significance in type 1 hypersensitivity. Clin Exp Immunol 65;416-426
108. Gauchat JF, Henchoz S, Mazzei G, Aubry JP, Brunner T, Blasey H, Life P, Talabot D, Flores-Romo L, Thompson J. 1993. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 365;340-343
109. 2. Prostaglandins 35;277-300
110. Godard P, Aubas P, Calvayrac P, Taib J, Michel F. 1981. Endoscopie et lavage bronchiolo-alvéolaire chez l'asthmatique. La nouvelle Press Méd 10;3141-3148
111. 14C-histamine given intrabronchially to asthmatic patients. Allergy 35;31-36
112. Granerus G, Simonsson BG, Skoogh BE, Wetterqvist H. 1971. Exercise-induced bronchoconstriction and histamine release. Scand J Respir Dis 52;131-136
113. Groot CA, Lammers JW, Molema J, Festen J, Van Herwaarden CL. 1992. Effect of inhaled beclomethasone and nedocromil sodium on bronchial hyperresponsiveness to histamine and distilled water. Eur Respir J 5;1075-1082
114. Hagenfeldt L, Paasikivi J, Sjogren A. 1973. Plasma levels of free polyunsaturated fatty acids in patients with ischemic heart disease. Metabolism 23;1349-1356
115. Hagermark O, Hokfelt T, Pernow B. 1978. Flare and itch induced by substance P in human skin. J Invest Dermatol 71;233-235
116. 2 in the presence of serum albumin. Biochim Biophys Acta 431;189-183
117. 2 in man. J Biol Chem 246;6713-6721
118. Hamberg M, Svensson J, Samuelsson B. 1975. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci U S A 72;2994-2998
119. Hanna CJ, Bach MK, Pare PD, Schellenberg RR. 1981. Slow-reacting substances (leukotrienes) contract human airway and pulmonary vascular smooth muscle in vitro. Nature 290;343-344
120. Hargreave FE, Ryan G, Thomson NC, O'Byrne PM, Latimer K, Juniper EF, Dolovich J. 1981. Bronchial responsive-ness to histamine or methacholine in asthma measurement and clinical significance. J Allergy Clin Immunol 68;347-355
121. Haskard DO, Lee TH. 1992. The role of leukocyte-endothelial interactions in the accumulation of leukocytes in allergic inflammation. Am Rev Respir Dis 145;S10-13
122. Hayaishi O. 1998. Prostaglandins and sleep. Nippon Rinsho 56;285-289
123. Heaney LG, Cross LJ, Ennis M. 1998. Histamine release from bronchoalveolar lavage cells from asthmatic subjects after allergen challenge and relationship to the late asthmatic response. Clin Exp Allergy 28;196-204
124. 2 in man. Prostaglandins 28;755-767
125. Hellewell PG, Williams TJ. 1986. A specific antagonist of platelet-activating factor suppresses oedema formation in an Arthus reaction but not oedema induced by leukocyte chemoattractants in rabbit skin. J Immunol 137;302-307
126. Henderson WR, Jr. 1987. Lipid-derived and other chemical mediators of inflammation in the lung. J Allergy Clin Immunol 79;543-553
127. Hermann K, Hertenberger B, Ring J. 1993. Measurement and characterization of histamine and methylhistamine in human urine under histamine-rich and histamine-poor diets. Int Arch Allergy Imm 101;13-19
128. Hoag JE, McFadden ER, Jr. 1991. Long-term effect of cromolyn sodium on nonspecific bronchial hyperresponsiveness: a review. Ann Allergy 66;53-63
129. Holgate ST. 1996. The immunopharmacology of mild asthma. J Allergy Clin Immunol 98;S7-16; discussion S33-40
130. Holgate ST, Bradding P, Sampson AP. 1996. Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy. J Allergy Clin Immunol 98;1-13
131. 2 to 9 alpha, 11 beta-prostaglandin F2 and its subsequent metabolism in rat, rabbit and guinea pig. Biochem Pharmacol 37;3591-3599
132. Howarth PH, Durham SR, Lee TH, Kay AB, Church MK, Holgate ST. 1985. Influence of albuterol, cromolyn sodium and ipratropium bromide on the airway and circulating mediator responses to allergen bronchial provocation in asthma. Am Rev Respir Dis 132;986-992
133. Howarth PH, Pao GJ, Church MK, Holgate ST. 1984. Exercise and isocapnic hyperventilation-induced broncho-constriction in asthma: relevance of circulating basophils to measurements of plasma histamine. J Allergy Clin Immunol 73;391-399
134. Hsueh W, Desai U, Gonzalez-Crussi F, Lamb R, Chu A. 1981. Two phospholipase pools for prostaglandin synthesis in macrophages. Nature 290;710-713
135. Hsueh W, Gonzalez-Crussi F, Hanneman E. 1980. Prostaglandin synthesis in different phases of phagocytosis in lung macrophages. Nature 283;80-82
136. Hsueh W, Kuhn Cd, Needleman P. 1979. Relationship of prostaglandin secretion by rabbit alveolar macrophages to phagocytosis and lysosomal enzyme release. Biochemical Journal 184;345-354
137. Hugh TE, Muller-Eberhard HJ. 1978. Anaphylatoxins: C3a and C5a. Adv Immunol 26;1-53
138. Igarashi Y, Kaliner MA, Hausfeld JN, Irani AA, Schwartz LB, White MV. 1993. Quantification of resident inflammatory cells in the human nasal mucosa. J Allergy Clin Immunol 91;1082-1093
139. Imokawa S, Sato A, Taniguchi M, Toyoshima M, Nakazawa K, Hayakawa H, Chida K. 1992. Sodium cromoglycate nebulized solution has an acute bronchodilative effect in patients with aspirin-intolerant asthma (AIA). Arerugi - Japanese Journal of Allergology 41;1515-1520
140. Irani AA, Craig SS, Nilsson G, Ishizaka T, Schwartz LB. 1992. Characterization of human mast cells developed in vitro from fetal liver cells cocultured with murine 3T3 fibroblasts. Immunology 77;136-143
141. Irani AM, Goldstein SM, Wintroub BU, Bradford T, Schwartz LB. 1991. Human mast cell carboxypeptidase. Selective localization to MCTC cells. J Immunol 147;247-253
142. Irani AM, Schwartz LB. Human mast cell heterogeneity. 1994. Allergy Proc 15;303-308
143. Ishikaza T, Furitsu T, Mitsui H, Takei M, Kozloski M, Irani A-M, Schwartz L, Dvorak A, Zsebo K, Gillis S. 1992. Development of human mast cells from umbilical cord blood cells by human and murine c-KIT ligand. FASEB J 6;A1403
144. Ishizaka T, Sian CM, Ishizaka K. 1972. Complement fixation by aggregated IgE through alternate pathway. J Immunol 108;848-851
145. Israel E, Dermarkarian R, Rosenberg M, Sperling R, Taylor G, Rubin P, Drazen JM. 1990. The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air. N Engl J Med 323;1740-1744
146. Israel E, Fischer AR, Rosenberg MA, Lilly CM, Callery JC, Shapiro J, Cohn J, Rubin P, Drazen JM. 1993. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin. Am Rev Respir Dis 148;1447-1451
147. Jarjour NN, Calhoun WJ. 1992. Exercise-induced asthma is not associated with mast cell activation or airway inflammation. J Allergy Clin Immunol 89;60-68
148. Jenkins CJ, Breslin AB. 1987. Long term study of the effect of sodium cromoglycate on non-specific bronchial hyperresponsiveness. Thorax 42;664-649
149. Joad J, Casale T. 1987. Airway histamine H1 receptors. In: Current toics in pulmonary pharmacology and toxicology (Hollinger, M, eds) Elsevier, New York, pp. 95-121
150. Kargman S, Vickers PJ, Evans JF. 1992. A23187-induced translocation of 5-lipoxygenase in osteosarcoma cells. J Cell Biol 119;1701-1709
151. Kauffman HF, van der Heide S, de Monchy JG, de Vries K. 1983. Plasma histamine concentrations and complement activation during house dust mite-provoked bronchial obstructive reactions. Clin Allergy 13;219-228
152. 4 and platelet-activating factor on airway reactivity in normal subjects. Am Rev Respir Dis 141;993-997
153. 4 in normal subjects. Am Rev Respir Dis 133;1127-1132
154. Keyzer JJ, Breukelman H, Wolthers BG, Richardson FJ, De Monchy JG. 1985. Measurement of N tau-methylhistamine concentrations in plasma and urine as a parameter for histamine release during anaphylactoid reactions. Agents Actions 16;76-79
155. Keyzer JJ, Kauffman HF, De Monchy JG, Keyzer-Udding JJ, De Vries K. 1984. Urinary N tau-methylhistamine during early and late allergen-induced bronchial-obstructive reactions. J Allergy Clin Immunol 74;240-245
156. Kirby JG, Hargreave FE, Cockcroft DW, O'Byrne PM. 1989. Effect of indomethacin on allergen-induced asthmatic responses. J Appl Physiol 66;578-583
157. Kirshenbaum AS, Kessler SW, Goff JP, Metcalfe DD. 1991. Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells. Journal of Immunology 146;1410-1415
158. Kitamura Y, Go S, Hatanaka K. 1978. Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation Blood 52;447-452
159. Koshino T, Arai Y, Miyamoto Y, Sano Y, Takaishi T, Hirai K, Ito K, Morita Y. 1995. Mast cell and basophil number in the airway correlate with the bronchial responsiveness of asthmatics. Int Arch Allergy Immunol 107;378-379
160. Kovacs EJ. 1991. Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. Immunol Today 12;17-23
161. Kowalski ML, Kaliner MA. 1988. Neurogenic inflammation, vascular permeability, and mast cells. J Immunol 140;3905-3911
162. Kroegel C, Matthys H. 1993. Platelet-activating factor-induced human eosinophil activation. Generation and release of cyclooxygenase metabolites in human blood eosinophils from asthmatics. Immunology 78;279-285
163. 4, and histamine in asthmatics. Am Rev Respir Dis 146;96-103
164. Kumlin M, Dahlén SE. 1990. Characteristics of formation and further metabolism of leukotrienes in the chopped human lung. Biochim Biophys Acta 1044;201-210
165. 2 receptor antagonists in guinea pigs. Eur J Pharmacol 238;335-341
166. Lagunoff D, Martin TW, Read G. 1983. Agents that release histamine from mast cells. Annu Rev Pharmacol Toxicol 23;331-351 (1983)
167. Lai CK, Polosa R, Holgate ST. 1990. Effect of 15-(s)-hydroxyeicosatetraenoic acid on allergen-induced asthmatic responses. Am Rev Respir Dis 141;1423-1427
168. Laitinen LA, Heino M, Laitinen A, Kava T, Haahtela T. 1985. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis 131;599-606
169. 4 and granulocytic infiltration into asthmatic airways. Lancet 341;989-990
170. Lands W, Smith W. 1982. Prostaglandins and aracidonate metabolites. In: Methods Enzymol (Lands, W, Smith, W, eds) Academic Press, London, pp. 213-667
171. Lane SJ, Lee TH. 1996. Mast cell effector mechanisms. J Allergy Clin Immunol 98;S67-71; S71-2
172. Larsson KA, Eklund AG, Hansson LO, Isaksson BM, Malmberg PO. 1994. Swine dust causes intense airways inflammation in healthy subjects. Am J Respir Crit Care Med 150;913-977
173. Lee TH, Assoufi BK, Cromwell O, Kay AB. 1983. Exercise-induced asthma and the mast cell. Lancet 2;164-165
174. Lee TH, Brown MJ, Nagy L, Causon R, Walport MJ, Kay AB. 1982. Exercise-induced release of histamine and neutrophil chemotactic factor in atopic asthmatics. J Allergy Clin Immunol 70;73-81
175. Lee TH, Coligan JE, Homma T, McLane MF, Tachibana N, Essex M. 1984. Human T-cell leukemia virus-associated membrane antigens: identity of the major antigens recognized after virus infection. Proc Natl Acad Sci USA 81;3856-3860
176. Lee TH, Nagakura T, Papageorgiou N, Cromwell O, Iikura Y, Kay AB. 1984. Mediators in exercise-induced asthma. J Allergy Clin Immunol 73;634-639
177. Lee TH, Nagy L, Nagakura T, Walport MJ, Kay AB. 1982. Identification and partial characterization of an exercise-induced neutrophil chemotactic factor in
178. Leff J, Pizzichini E, Efthimiadis A, Boulet L, Wei L, Weinland D, Hendeles L, Hargreave F. 1997. Effect of Montelukast (MK-0476) on airway eosinophilc inflammation in mildly uncontrolled asthma: a randomised placebo-controlled trial. Am J Respir Crit Care Med 155;A977
179. Leonard EJ, Yoshimura T. 1990. Neutrophil attractant/activation protein-1 (NAP-1 [interleukin-8]). Am J Respir Cell Mol Biol 2;479-486
180. Lewis RA, Austen KF, Drazen JM, Clark DA, Marfat A, Corey EJ. 1980. Slow reacting substances of anaphylaxis: identification of leukotrienes C-1 and D from human and rat sources. Proc Natl Acad Sci USA 77;3710-3714
181. 2 generation after activation of rat and human mast cells with anti-IgE. J Immunol 129;1627-1631
182. 2 in a normal human male volunteer. J Biol Chem 260;13172-13180
183. 2): a unique biologically active prostaglandin produced enzymatically in vivo in humans. Proc Natl Acad Sci USA 82;6030-6034
184. Liu MC, Hubbard WC, Proud D, Stealey BA, Galli SJ, Kagey-Sobotka A, Bleecker ER, Lichtenstein LM. 1991 Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Cellular, mediator, and permeability changes. Am Rev Respir Dis 144;51-58
185. 2alpha, acetylcholine, histamine, and citric acid. Thorax 32;734-739
186. Love KS, Lakshmanan RR, Butterfield JH, Fox CC. 1996. IFN-gamma-stimulated enhancement of MHC class II antigen expression by the human mast cell line HMC-1. Cell Immunol 170;85-90
187. Lowhagen O, Rak S. 1985. Modification of bronchial hyperreactivity after treatment with sodium cromoglycate during pollen season. J Allergy Clin Immunol 75;460-467
188. 4, and prostanoids by human alveolar macrophages: analysis by gas chromatography/mass spectrometry. Prostaglandins 27;163-179
189. MacDonald SM, Lichtenstein LM, Proud D, Plaut M, Naclerio RM, MacGlashan DW, Kagey-Sobotka A. 1987. Studies of IgE-dependent histamine releasing factors: heterogeneity of IgE. J Immunol 139;506-512
190. MacGlashan DW, Jr., Schleimer RP, Peters SP, Schulman ES, Adams GK, Sobotka AK, Newball HH, Lichtenstein LM. 1983. Comparative studies of human basophils and mast cells. Fed Proc 42;2504-2509
191. 4 into vascular compartment in healthy subjects. Am J Physiol 263;H244-249
192. Mahmud I, Ueda N, Yamaguchi H, Yamashita R, Yamamoto S, Kanaoka Y, Urade Y, Hayaishi O. 1997. Prostaglandin D synthase in human megakaryoblastic cells. J Biol Chem 272;28263-28266
193. 4 elimination and metabolism in man. J Allergy Clin Immunol 85;3-9
194. Mancini JA, Abramovitz M, Cox ME, Wong E, Charleson S, Perrier H, Wang Z, Prasit P, Vickers PJ. 1993. 5-lipoxygenase-activating protein is an arachidonate binding protein. FEBS Letters 318;277-281 (1993)
195. 4 levels during early and late asthmatic responses. J Allergy Clin Immunol 86;211-220
196. 4-receptor antagonist. N Engl J Med 323;1736-1739
197. Marom Z, Shelhamer JH, Kaliner M. 1981. Effects of arachidonic acid, monohydroxyeicosatetraenoic acid and prostaglandins on the release of mucous glycoproteins from human airways in vitro. J Clin Invest 67;1695-1702
198. Marom Z, Shelhamer JH, Steel L, Goetzl EJ, Kaliner M. 1984. Prostaglandin-generating factor of anaphylaxis induces mucous glycoprotein release and the formation of lipoxygenase products of arachidonate from human airways. Prostaglandins 28;79-91
199. Marquardt DL, Parker CW, Sullivan TJ. 1978. Potentiation of mast cell mediator release by adenosine. J Immunol 120;871-878
200. 4 in the human lung. Recruitment of neutrophils into the alveolar spaces without a change in protein permeability. J Clin Invest 84;1609-1619
201. Martin TR, Takeishi T, Katz HR, Austen KF, Drazen JM, Galli SJ. 1993. Mast cell activation enhances airway responsiveness to methacholine in the mouse. J Clin Invest 91;1176-1182
202. Matin R, Tam EK, Nadel JA, Caughey GH. 1992. Distribution of chymase-containing mast cells in human bronchi. J Histochem Cytochem 40;781-786
203. Matthews G, Neher E, Penner R. 1989. Second messenger-activated calcium influx in rat peritoneal mast cells. J Physiol 418;105-130
204. Maximow A. 1905. Ueber die zellformen des lockeren bindegewebes. Arch. Mikroskop. Anat. Entw. Gesch. 67;680-757
205. Maxwell DL, Hawksworth RJ, Lee TH. 1993. Inhaled nedocromil sodium reduces histamine release from isolated large airway segments of asthmatic subjects in vivo [published erratum appears in Eur Respir J 1993 Nov;6(10):1578]. Eur Respir J 6;1145-1150
206. McFadden ER, Jr. 1987. Exercise and asthma. N Engl J Med 317;502-504
207. 2 by murine macrophage cell lines. Prostaglandins 30;949-967
208. Meade EA, Smith WL, DeWitt DL. 1993. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 268;6610-6614
209. Melegos DN, Diamandis EP, Oda H, Urade Y, Hayaishi O. 1996. Immunofluorometric assay of prostaglandin D synthase in human tissue extracts and fluids. Clin Chem 42;1984-1991
210. Melegos DN, Freedman MS, Diamandis EP. 1997. Prostaglandin D synthase concentration in cerebrospinal fluid and serum of patients with neurological disorders. Prostaglandins 54;463-474
211. Meltzer SS, Hasday JD, Cohn J, Bleecker ER. 1996. Inhibition of exercise-induced bronchospasm by zileuton: a 5-lipoxygenase inhibitor. Am J Respir Crit Care Med 153;931-935
212. Menon AK, Holowka D, Baird B. 1984. Small oligomers of immunoglobulin E (IgE) cause large-scale clustering of IgE receptors on the surface of rat basophilic leukemia cells. J Cell Biol 98;577-583
213. Metcalfe DD, Smith JA, Austen KF, Silbert JE. 1980. Polydispersity of rat mast cell heparin. Implications for proteoglycan assembly. J Biol Chem 255;11753-11758
214. Metzger WJ, Zavala D, Richerson HB, Moseley P, Iwamota P, Monick M, Sjoerdsma K, Hunninghake GW. 1987. Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs. Description of the model and local airway inflammation. Am Rev Respir Dis 135;433-440
215. Michels N. The mast cell. 1963. In: Handbook of Heamatology (Downey, H, Paul, B, eds) Ann NY Acad Sci, pp. 103-235
216. Miller DK, Gillard JW, Vickers PJ, Sadowski S, Leveille C, Mancini JA, Charleson P, Dixon RA, Ford-Hutchinson AW, Fortin R. 1990. Identification and isolation of a membrane protein necessary for leukotriene production. Nature 343;278-281
217. Miller JS, Moxley G, Schwartz LB. 1990. Cloning and characterization of a second complementary DNA for human tryptase. J Clin Invest 86;864-870
218. Moller A, Lippert U, Lessmann D, Kolde G, Hamann K, Welker P, Schadendorf D, Rosenbach T, Luger T, Czarnetzki BM. 1993. Human mast cells produce IL-8. J Immunol 151;3261-3266
219. Monroe JG, Haldar S, Prystowsky MB, Lammie P. Lymphokine regulation of inflammatory processes: interleukin-4 stimulates fibroblast proliferation 1988. Clin Immunol Immunopath 49;292-298
220. Morel AM, Delaage MA 1988. Immunoanalysis of histamine through a novel chemical derivatization [published erratum appears in J Allergy Clin Immunol 1989 Mar;83(3):704-5]. J Allergy Clin Immunol 82;646-654
221. Moreno RH, Hogg JC, Pare PD. 1986. Mechanics of airway narrowing. Am Rev Respir Dis 133;1171-1180
222. 2 by cultured human alveolar macrophages. Nippon Kyobu Shikkan Gakkai Zasshi 27;1322-1329
223. Morley J, Bray MA, Jones RW, Nugteren DH, Van Dorp DA. 1979. Prostaglandin and thromboxane production by human and guinea-pig macrophages and leucocytes. Prostaglandins 17;729-746
224. Morris HR, Taylor GW, Piper PJ, Tippins JR. 1980. Structure of slow-reacting substance of anaphylaxis from guinea-pig lung. Nature 285;104-106
225. 2. J Invest Dermatol 104;937-940
226. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci U S A 87;9383-9387
227. Morrow JD, Margolies GR, Rowland J, Roberts LJ II. 1991. Evidence that histamine is the causative toxin of scombroid-fish poisoning. N Engl J Med 324;716-720
228. 2 alpha, is formed in vivo. Biochim Biophys Acta 1210;244-248
229. 2 by a stable isotope dilution mass spectrometric assay. Anal Biochem 193;142-148
230. Munoz NM, Shioya T, Murphy TM, Primack S, Dame C, Sands MF, Leff AR. 1986. Potentiation of vagal contractile response by thromboxane mimetic U-46619. J Appl Physiol 61;1173-1179
231. Murphy RC, Hammarstrom S, Samuelsson B. 1979. Leukotriene C: a slow-reacting substance from murine mastocytoma cells. Proc Natl Acad Sci USA 76;4215-4279
232. 2 into human airways during acute antigen challenge. N Engl J Med 315;800-804
233. Naclerio RM, Meier HL, Kagey-Sobotka A, Adkinson NF, Jr., Meyers DA, Norman PS, Lichtenstein LM. 1983. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis 128;597-602
234. Nagakura T, Lee TH, Assoufi BK, Newman-Taylor AJ, Denison DM, Kay AB. 1983. Neutrophil chemotactic factor in exercise- and hyperventilation-induced asthma. Am Rev Respir Dis 128;294-296
235. 2 in acute and exercise-induced asthma in children. Clin Exp Allergy 28;181-186
236. Nasser SM, Pfister R, Christie PE, Sousa AR, Barker J, Schmitz-Schumann M, Lee TH. 1996. Inflammatory cell populations in bronchial biopsies from aspirin-sensitive asthmatic subjects. Am J Respir Crit Care Med 153;90-96
237. Nilsson G, Butterfield JH, Nilsson K, Siegbahn A. 1994. Stem cell factor is a chemotactic factor for human mast cells. J Immunol 153;3717-3723
238. Noah J. 1961. A flourometric method to determine levels of histamine in human plasma. J Allergy 32;236-240
239. 2-isoprostanes as indicators of non-enzymatic lipid peroxidation in vivo by gas chromatography-mass spectrometry: development of a solid-phase extraction procedure. J Chromatogr B Biomed Appl 667;199-208
240. Nugteren DH, Hazelhof E. 1973. Isolation and properties of intermediates in prostaglandin biosynthesis. Biochim Biophys Acta 326;448-461
241. 2 in human urine and plasma by gas chromatography-mass spectrometry. J Chromatogr B Biomed Appl 655;173-178
242. 2 by human platelets. Prostaglandins 13;225-234
243. 4 enhance histamine responsiveness in asthmatic airways. Am Rev Respir Dis 144;1053-1057
244. Ohkawara Y, Yamauchi K, Tanno Y, Tamura G, Ohtani H, Nagura H, Ohkuda K, Takishima T. 1992. Human lung mast cells and pulmonary macrophages produce tumor necrosis factor-alpha in sensitized lung tissue after IgE receptor triggering. Am J Respir Cell Mol Biol 7;385-392
245. Oosting E, Keyzer JJ. 1991. Measurement of urinary N tau-methylhistamine excretion: correlation of a newly developed radioimmunoassay (RIA) with gas chromatography mass spectrometiy (GCMS). Agents Actions 33;215-217
246. Orehek J. 1981. Neurohumoral control of airway caliber. Int Rev Physiol 23;1-74
247. 4. Biochem Biophys Res Commun 130;214-220
248. 2 compounds by human eosinophils. A potential mast cell-eosinophil interaction. J Immunol 141;2413-2419
249. Patrono C, Ciabattoni G, Pugliese F, Pierucci A, Blair I, FitzGerald G. 1986. Estimated rate of thromboxane secretion-into the circulation of normal humans. J Clin Invest 77;590-594
250. 2 on allergen-induced asthma. Am Rev Respir Dis 148;87-90
251. Peachell PT, Columbo M, Kagey-Sobotka A, Lichtenstein LM, Marone G. 1988. Adenosine potentiates mediator release from human lung mast cells. Am Rev Respir Dis 138;1143-1151
252. Pearce CA, Greaves MW, Plummer VM, Yamamoto S. 1974. Effect of disodium cromoglycate on antigen-evoked histamine release from human skin. Clin Exp Immunol 17;437-440
253. Pedersen B, Dahl R, Larsen BB, Venge P. 1993. The effect of salmeterol on the early- and late-phase reaction to bronchial allergen and postchallenge variation in bronchial reactivity, blood eosinophils, serum eosinophil cationic protein, and serum eosinophil protein X. Allergy: Eur J Allergy Clin Immunol 48;377-382 (1993)
254. Pepys J, Hargreave FE, Chan M, McCarthy DS. 1968. Inhibitory effects of disodium cromoglycate on allergen-inhalation tests. Lancet 2;134-137
255. Persson CG. 1991. Mucosal exudation in respiratory defence: neural or non-neural control? Int Arch Allergy Appl Immunol 94;222-226
256. Peterson C, Enander I, Lindgren D, Nordvall S, Alving K. 1996. Measurement and characterisation of eosinophil protein X (EPX) in urine. Am J Respir Crit Care Med 153;A201
257. 2 on airway caliber in asthma. J Appl Physiol 66;304-312
258. Picado C, Ramis I, Rosello J, Prat J, Bulbena O, Plaza V, Montserrat JM, Gelpi E. 1992. Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients. Am Rev Respir Dis 145;65-69
259. Pin I, Freitag AP, O'Byrne PM, Girgis-Gabardo A, Watson RM, Dolovich J, Denburg JA, Hargreave FE. 1992. Changes in the cellular profile of induced sputum after allergen-induced asthmatic responses. Am Rev Respir Dis 145;12651269
260. 4 in guinea-pig lung in vitro. Br J Pharmacol 77;267-275
261. 2alpha by human monocytes. Discriminate production by reactive oxygen species and prostaglandin endoperoxide synthase-2. J Biol Chem 271;8919-8924
262. 2 alpha by human platelets. Adv Prostaglandin Thromboxane Leukot Res 23;229-231
263. Proud D, Baumgarten CR, Naclerio RM, Lichtenstein LM. 1986. The role of kinins in human allergic disease. N Engl Reg Allergy Proc 7;213-218 (1986)
264. 2, that inhibits platelet aggregation and constricts blood vessels. J Biol Chem 260;14621-14625
265. Rafferty P, Holgate ST. 1989. Histamine and its antagonists in asthma. J Allergy Clin Immunol 84;144-151
266. 4 and neutrophil attractant/activation protein (interleukin 8) sequentially in response to stimulation with lipopolysaccharide and zymosan. J Clin Invest 86;1556-1564
267. 4 antagonist, L-648,051. Allergy 47;599-603
268. Raud J. 1990. Vasodilatation and inhibition of mediator release represent two distinct mechanisms for prostaglandin modulation of acute mast cell-dependent inflammation. Br J Pharmacol 99;449-454
269. 2: apparent correlation with in vivo modulation of mediator release. Proc Natl Acad Sci U S A 85;2315-2319
270. Raud J, Hallden G, Roquet A, Van Hage-Hamsten M, Alkner U, Hed J, Zetterstrom O, Dahlén SE, Hedqvist P, Gronneberg R. 1996. Anti-IgE-induced accumulation of leukocytes, mediators, and albumin in skin chamber fluid from healthy and atopic subjects. J Allergy Clin Immunol 97;1151-1163
271. Rauls DO, Ting S, Lund M. 1986. Analysis of plasma histamine: a modification of the enzymatic isotopic assay. J Allergy Clin Immunol 77;673-676
272. Raz A, Wyche A, Needleman P. 1989. Temporal and pharmacological division of fibroblast cyclooxygenase expression into transcriptional and translational phases. Proc Natl Acad Sci U S A 86;1657-1661
273. 4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist. Thorax 52;1030-1035
274. Repke H, Bienert M. 1987. Mast cell activation - a receptor-independent mode of substance P action? FEBS Letters 221;236-240
275. 3 from rat peritoneal mast cells. J Pharmacol Exp Ther 243;317-321
276. Richardson PS, Peatfield AC. 1987. The control of airway mucus secretion. Eur J Respir Dis Suppl 153;43-51
277. Ring J, Sedlmeier F, Von der Helm D, Mayr T, Walz U, Ibel H, Riepel H, Przybilla B, Reimann H, Dorsch W. 1986. Histamine an allergic diseases. In: New trends in allergy (Ring, J, Burg, G, eds) Springer-Verlag, Berlin, pp. 44-77
278. Roberts LJ II, Morrow JD. 1997. The generation and actions of isoprostanes. Biochim Biophys Acta 1345;121-135
279. Roberts LJ II, Oates JA. 1991. Biochemical diagnosis of systemic mast cell disorders. J Invest Dermatol 96;19S-24S
280. 2, which contracts human coronary artery rings. Adv Prostaglandin, Thromboxane, & Leukotriene Res 17A;427-429
281. 2 in patients with systemic mastocytosis. N Engl J Med 303;1400-1404
282. Robinson C, Holgate ST. 1985. Mast cell-dependent inflammatory mediators and their putative role in bronchial asthma. Clin Sci 68;103-112
283. Robuschi M, Gambaro G, Sestini P, Pieroni MG, Refini RM, Vaghi A, Bianco S. 1997. Attenuation of aspirin-induced bronchoconstriction by sodium cromoglycate and nedocromil sodium. Am J Respir Crit Care Med 155;1461-1464
284. Robuschi M, Riva E, Fuccella LM, Vida E, Barnabe R, Rossi M, Gambaro G, Spagnotto S, Bianco S. 1992. Prevention of exercise-induced bronchoconstriction by a new leukotriene antagonist (SK&F 104353), A double-blind study versus disodium cromoglycate and placebo. Am Rev Respir Dis 145;1285-1288
285. Romagnani S. 1992. Induction of TH1 and TH2 responses: a key role for the 'natural' immune response?. Immunol Today 13;379-381
286. Roquet A, Dahlen B, Kumlin M, Ihre E, Anstren G, Binks S, Dahlén SE. 1997. Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics. Am J Respir Crit Care Med 155;1856-1863
287. Rouzer CA, Scott WA, Cohn ZA, Blackburn P, Manning JM. 1980. Mouse peritoneal macrophages release leukotriene C in response to a phagocytic stimulus. Proc Natl Acad Sci U S A 77;4928-4932
288. Rouzer CA, Scott WA, Hamill AL, Cohn ZA. 1982. Synthesis of leukotriene C and other arachidonic acid metabolites by mouse pulmonary macrophages. J Exp Med 155;720-733
289. Ruger B, Dunbar PR, Hasan Q, Sawada H, Kittelberger R, Gieenhill N, Neale TJ. 1994. Human mast cells produce type VIII collagen in vivo. Intl J Exp Path 75;397-404
290. Rumsaeng V, Cruikshank W, Foster B, Kornfeld H, Cenetr D, Metcalfe D. 1996. Interleukin-16 production by human leukemic mast cells (HMC-1). FASEB J 10;A1308
291. Ruoss SJ, Hartmann T, Caughey GH 1991.. Mast cell tryptase is a mitogen for cultured fibroblasts. J Clin Invest 88;493-499
292. 4 elimination and metabolism in normal human subjects. J Biol Chem 265;21771-21778
293. Salter H, 1859. On asthma: its pathology and treatment. London: Churchill. 24-60.
294. 4 in normal and in asthmatic subjects. Am J Respir Crit Care Med 155;1789-179
295. Samter M, Beers RF, Jr. 1968. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med 68;975-983
296. Samuelsson B. 1972. Biosynthesis of prostaglandins. Fed Proc 31;1442-1450
297. Samuelsson B, Granstrom E, Green K, Hamberg M, Hammarstrom S. 1975. Prostaglandins. Annu Rev Biochem 44;669-695
298. Sandberg N. 1962. Acclerated collagen formation and histamine. Nature 194;183
299. Schechter NM, Irani AM, Sprows JL, Abernethy J, Wintroub B, Schwartz LB. 1990. Identification of a cathepsin G-like proteinase in the MCTC type of human mast cell. J Immunol 145;2652-2661
300. Schleimer R, Gillespie I, Daiuta R, Lichtenstein L. 1981. Release of histamine from human leukocytes stimulated with the tumor promoting phorbol diesters. II. Interaction with other stimuli. J Immunol 226;136-140
301. Schleimer RP, Sterbinsky SA, Kaiser J, Bickel CA, Klunk DA, Tomioka K, Newman W, Luscinskas FW, Gimbrone MA, Jr., McIntyre BW. 1992. EL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J Immunol 148;1086-1092
302. Schulman ES, Adkinson NF, Jr., Newball HH. 1982. Cyclooxygenase metabolites in human lung anaphylaxis: airway vs. parenchyma. J Appl Physiol 53;589-595
303. Schulman ES, Kagey-Sobotka A, MacGlashan DW, Jr., Adkinson NF, Jr., Peters SP, Schleimer RP, Lichtenstein LM. 1983. Heterogeneity of human mast cells. J Immunol 131;1936-1940
304. Schwartz LB, Bradford TR. 1986. Regulation of tryptase from human lung mast cells by heparin. Stabilization of the active tetramer. J Biol Chem 261;7372-7379
305. Schwartz LB, Bradford TR, Lee DC, Chlebowski JF. 1990. Immunologic and physicochemical evidence for conformational changes occurring on conversion of human mast cell tryptase from active tetramer to inactive monomer. Production of monoclonal antibodies recognizing active tryptase. J Immunol 144;2304-2311
306. Schwartz LB, Bradford TR, Littman BH, Wintroub BU. 1985. The fibrinogenolytic activity of purified tryptase from human lung mast cells. J Immunol 135;2762-2767
307. Schwartz LB, Bradford TR, Rouse C, Irani AM, Rasp G, Van der Zwan JK, Van der Linden PW. 1994. Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis. J Clin Immunol 14;190-204
308. Schwartz LB, Irani AM, Roller K, Castells MC, Schechter NM. 1987. Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells. J Immunol 138;2611-2615
309. Schwartz LB, Metcalfe DD, Miller JS, Earl H, Sullivan T. 1987. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med 316;1622-1626
310. Schwartz LB, Sakai K, Bradford TR, Ren S, Zweiman B, Worobec AS, Metcalfe DD. 1995. The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. J ClinInvest 96;2702-2710
311. Schwartz LB, Yunginger JW, Miller J, Bokhari R, Dull D. 1989. Time course of appearance and disappearance of human mast cell typtase in the circulation after anaphylaxis. J Clin Invest 83;1551-1555
312. 2 alpha in humans. J Mass Spectrom 32;1362-1370
313. 2): formation and metabolism by human lung and contractile effects on human bronchial smooth muscle. Proc Natl Acad Sci USA 84;256-260
314. 4 excretion in aspirin-sensitive asthma. Am J Respir Crit Care Med 153;572-575
315. Shimizu T, Yamamoto S, Hayaishi O. 1979. Purification and properties of prostaglandin D synthetase from rat brain. J Biol Chem 254;5222-5228
316. Silverman M, Andrea T. 1972. Time course of effect of disodium cromoglycate on exercise-induced asthma. Arch Dis Child 47;419-422
317. Siraganian RP. 1974. An automated continuous-flow system for the extraction and fluorometric analysis of histamine. Anal Biochem 57;383-394
318. Sladek K, Dworski R, Soja J, Sheller JR, Nizankowska E, Oates JA, Szczeklik A. 1994. Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge. Am J Respir Crit Care Med 149;940-946
319. 4 levels after allergen and exercise challenge in bronchial asthma. Am Rev Respir Dis 144;1411-1413
320. 2 inhibits the aggregation of human platelets. Thromb Res 5;291-299
321. Smith JB, Willis AL. 1971. Aspirin selectively inhibits prostaglandin production in human platelets. Nature - New Biology 231;235-237
322. 4 in humans. Am Rev Respir Dis 131;368-372
323. Smith LJ, Rubin AH, Patterson R. 1988. Mechanism of platelet activating factor-induced bronchoconstriction in humans. AmRev Respir Dis 137;1015-1019
324. 4) in human skin. J Invest Dermatol 80;115-119
325. Sousa A, Pfister R, Christie PE, Lane SJ, Nasser SM, Schmitz-Schumann M, Lee TH. 1997. Enhanced expression of cyclooxygenase isoenzyme 2 (COX-2) in asthmatic airways and its cellular distribution in aspirin-sensitive asthma. Thorax 52;940-945
326. Sperber K, Goswami SK, Gollub E, Mayer L, Marom Z. 1991. Mucus secretagogue production by a human macrophage hybridoma. J Allergy Clin Immunol 87;490-498
327. Stephan V, Zimmermann A, Kuhr J, Urbanek R. Determination of N-methylhistamine in urine as an indicator of histamine release in immediate allergic reactions. J Allergy Clin Immunol 86;862-868
328. Stevenson DD. 1984. Diagnosis, prevention, and treatment of adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs. J Allergy Clin Immunol 74;617-622
329. Stricter RM, Kasahara K, Allen RM, Standiford TJ, Rolfe MW, Becker FS, Chensue SW, Kunkel SL. 1992. Cytokine-induced neutrophil-derived interleukin-8. Am J Pathol 141;397-407
330. Strobel S, Miller HR, Ferguson A. 1981. Human intestinal mucosal mast cells: evaluation of fixation and staining techniques. J Clin Pathol 34;851-858
331. Sturk A, ten Cate JW, Hosford D, Mencia-Huerta JM, Braquet P. 1989. The synthesis, catabolism, and pathophysiological role of platelet-activating factor. Adv Lipid Res 23;219-216
332. Szczeklik A. 1994. Mediator assays in aspirin-induced asthma. Allergy Proc 15;135-138
333. Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G. 1975. Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. Br Med J 1;67-69
334. Szczeklik A, Mastalerz L, Nizankowska E, Cmiel A. 1996. Protective and bronchodilator effects of prostaglandin E and salbutamol in aspirin-induced asthma. Am J Respir Crit Care Med 153;567-571
335. Szczeklik A, Sladek K, Dworski R, Nizankowska E, Soja J, Sheller J, Oates J. 1996. Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics. Am J Respir Crit Care Med 154;1608-1614
336. 4 excretion in allergic asthmatics after inhaled antigen. Eicosanoids 3;75-80
337. Tanaka DT, Grunstein MM. 1986. Effect of substance P on neurally mediated contraction of rabbit airway smooth muscle. J Appl Physiol 60;458-463
338. Tanus T, Mines D, Atkins PC, Levinson AI. 1994. Serum tryptase in idiopathic anaphylaxis: a case report and review of the literature. Ann Emerg Med 24;104-107
339. 4 after antigen challenge and in acute asthma and allergic rhinitis. Lancet 1;584-588
340. Taylor IK, O'Shaughnessy KM, Fuller RW, Dollery CT. 1991. Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects. Lancet 337;690-694
341. 4 excretion in exercise-induced asthma. J Appl Physiol 73;743-748
342. Tkaczyk C, Frandji P, Botros HG, Poncet P, Lapeyre J, Peronet R, David B, Mecheri S. 1996. Mouse bone marrow-derived mast cells and mast cell lines constitutively produce B cell growth and differentiation activities. J Immunol 157;1720-1728
343. Togias AG, Naclerio RM, Proud D, Fish JE, Adkinson NF, Jr., Kagey-Sobotka A, Norman PS, Lichtenstein LM. 1985. Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement. J Clin Invest 76;1375-1381
344. Togias AG, Proud D, Lichtenstein LM, Adams GK II, Norman PS, Kagey-Sobotka A, Naclerio RM. 1988. The osmolality of nasal secretions increases when inflammatory mediators are released in response to inhalation of cold, dry air. Am Rev Respir Dis 137;625-629
345. 2 from swine brain. J Biol Chem 257;13576-13580
346. 2
347. 4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody. Am J Respir Crit Care Med 154;850-857
348. Uvnas B, Aborg CH. 1984. Cation exchange - a common mechanism in the storage and release of biogenic amines stored in granules (vesicles)? II. Comparative studies on sodium-induced release of biogenic amines from the synthetic weak cation-exchangers Amberlite IRC-50 and duolite CS-100 and from biogenic (granule-enriched) materials. Acta Physiol Scand 120;87-97
349. Valent P, Spanblochl E, Sperr WR, Sillaber C, Zsebo KM, Agis H, Strobl H, Geissler K, Bettelheim P, Lechner K. 1992. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture. Blood 80;2237-2245
350. Vanderslice P, Ballinger SM, Tam EK, Goldstein SM, Craik CS, Caughey GH. 1990. Human mast cell tryptase: multiple cDNAs and genes reveal a multigene serine protease family. Proc Natl Acad Sci USA 87;3811-3815
351. Vane J, Botting R. 1998. Mechanism of action of anti-inflammatory drugs: an overview. In: Selective COX-2 inhibitors. Pharmacology, clinical effects and therapeutic potential (Vane, SJ, Botting, DJ, eds) William Harvey Press, London, pp. 1-17
352. Vane JR. 1971. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature - New Biology 231;232-235
353. Ventura MT, Bruno LM, Iacobelli A, Tursi A. 1997. Eosinophils in allergic diseases: immunopharmacological regulation. Immunopharmacol Immunotoxicol 19;405-423
354. 4 by human individuals. Biochem Biophys Res Commun 148;864-868
355. Walsh GM, Mermod JJ, Hartnell A, Kay AB, Wardlaw AJ. 1991. Human eosinophil, but not neutrophil, adherence to IL-1-stimulated human umbilical vascular endothelial cells is alpha 4 beta 1 (very late antigen-4) dependent. J Immunol 146;3419-3423
356. 2 alpha excretion in man. J Pharmacol Exp Ther 275;94-100
357. Wang Z, Malmberg P, Larsson P, Larsson BM, Larsson K. 1996. Time course of interleukin-6 and tumor necrosis factor-alpha increase in serum following inhalation of swine dust. Am J Respir Crit Care Med 153;147-152
358. Wasserman SI. 1987. The regulation of inflammatory mediator production by mast cell products. American RevRespiR Dis 135;S46-48
359. Wasserman SI, Soter NA, Center DM, Austen KF. 1977. Cold urticaria. Recognition and characterization of a neutrophil chemotactic factor which appears in serum during experimental cold challenge. J Clin Invest 60;189-196
360. Weidner N, Austen KF. 1993. Heterogeneity of mast cells at multiple body sites. Fluorescent determination of avidin binding and immunofluorescent determination of chymase, tryptase, and carboxypeptidase content. Pathol, Res Pract 189;156-162
361. Welle M. 1997. Development, significance, and heterogeneity of mast cells with particular regard to the mast cell-specific proteases chymase and tryptase. J Leukoc Biol 61;233-245
362. 2 by stable isotope dilution mass spectrometric assay. Methods Enzymol 187;51-62
363. Wennogle LP, Liang H, Quintavalla JC, Bowen BR, Wasvary J, Miller DB, Allentoff A, Boyer W, Kelly M, Marshall P. 1995. Comparison of recombinant cyclooxygenase-2 to native isoforms: aspirin labeling of the active site. FEBS Lett 371;315-320
364. Wenzel S, Irani AM, Sanders JM, Bradford TR, Schwartz LB. 1996. Immunoassay of tryptase from human mast cells. J Immunol Methods 86;139-142
365. Wenzel SE, Fowler AA II, Schwartz LB. 1988. Activation of pulmonary mast cells by bronchoalveolar allergen challenge. In vivo release of histamine and tryptase in atopic subjects with and without asthma. Am Rev Respir Dis 137;1002-1008
366. 4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge. Am Rev Respir Dis 142;112-119
367. 4 in patients with asthma. Effect of airways reactivity and sodium cromoglycate. Am Rev Respir Dis 143;1322-1328
368. White MV. 1990. The role of histamine in allergic diseases. J Allergy Clin Immunol 86;599-605
369. White MV, Slater JE, Kaliner MA. 1987. Histamine and asthma. Am Rev Respir Dis 135;1165-1176
370. Wood-Baker R, Finnerty JP, Holgate ST. 1993. Plasma and urinary histamine in allergen-induced early and late phase asthmatic responses. Eur Respir J 6;1138-1144
371. Woolley KL, Adelroth E, Woolley MJ, Ellis R, Jordana M, O'Byrne PM. 1995. Effects of allergen challenge on eosinophils, eosinophil cationic protein, and granulocyte-macrophage colony-stimulating factor in mild asthma. Am J Respir Crit Care Med 151;1915-1924
372. Xie WL, Chipman JG, Robertson DL, Erikson RL, Simmons DL. 1991. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci U S A 88;2692-2696
373. Yamamoto H, Nagata M, Kuramitsu K, Tabe K, Kiuchi H, Sakamoto Y, Yamamoto K, Dohi Y. 1994. Inhibition of analgesic-induced asthma by leukotriene receptor antagonist ONO-1078. Am J Respir Crit Care Med 150;254-257
374. 4 excretion in aspirin-induced asthma. Ann Allergy Asthma Immunol 80;171-176
375. Zimmermann A, Urbanek R, Kuhr J, Stephan V. 1992. Urinary N-methylhistamine excretion. Following exogenous histamine administration and allergy/exercise-induced bronchoconstriction. Monatsschr Kinderheilkd 140;51-56